Will Chou, MD.

Company: Aruvant
Job title: CEO
Seminars:
Developing a Differentiated Gene Therapy for Sickle Cell Disease: Key Considerations 9:00 am
Aligning with regulatory requirements for quality of gene therapies, across CMC & clinical development Standing out from both a safety and efficacy perspective Developing therapies in a ‘crowded’ market – with respect to gene therapies in development and existing standards of careRead more
day: Day Two